Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:53 AM
Ignite Modification Date:
2025-12-25 @ 12:53 AM
NCT ID:
NCT02603367
Eligibility Criteria:
Inclusion Criteria:
* Family caregivers will need to be the primary family caregiver as identified by the lung cancer patient (ten caregivers from each of the following cancer care continuum points will be recruited)
* English-speaking
* Cancer care continuum points are defined as follows:
* Diagnosis: A lung cancer patient who has received diagnosis within the last 45 days but has not yet started treatment
* Treatment: A lung cancer patients who has started initial treatment (chemotherapy, radiation, surgery) for diagnosis within the last 30 days, is actively receiving treatment, and has a prognosis of more than one year
* Survivorship: A lung cancer patient who has completed treatment and who is clinically disease free at the time of caregiver enrollment to study
* End of Life: A lung cancer patient who is estimated to have 6 months or less to live
* All subjects must have the ability to understand and the willingness to participate in the informed consent process
Exclusion Criteria:
* Research participants who do not speak or read English
* Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02603367
Study Brief:
Protocol Section:
NCT02603367